Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

View ORCID ProfileEmmie de Wit, Friederike Feldmann, Jacqueline Cronin, Robert Jordan, Atsushi Okumura, Tina Thomas, Dana Scott, Tomas Cihlar, and Heinz Feldmann
PNAS March 24, 2020 117 (12) 6771-6776; first published February 13, 2020; https://doi.org/10.1073/pnas.1922083117
Emmie de Wit
aLaboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmie de Wit
  • For correspondence: Emmie.deWit@nih.gov
Friederike Feldmann
bRocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Cronin
aLaboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Jordan
cBiology Department, Gilead Sciences, Foster City, CA 94404;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Okumura
dCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Thomas
aLaboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana Scott
bRocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomas Cihlar
cBiology Department, Gilead Sciences, Foster City, CA 94404;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heinz Feldmann
aLaboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  1. Edited by Michael B. A. Oldstone, Scripps Research Institute, La Jolla, CA, and approved February 7, 2020 (received for review December 16, 2019)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Online Impact

 

Article Information

vol. 117 no. 12 6771-6776
DOI: 
https://doi.org/10.1073/pnas.1922083117
PubMed: 
32054787

Published By: 
National Academy of Sciences
Print ISSN: 
0027-8424
Online ISSN: 
1091-6490
History: 
  • Published in issue March 24, 2020.
  • Published first February 13, 2020.

Article Versions

  • Previous version (February 13, 2020 - 11:24).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
Copyright © 2020 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).

Author Information

  1. Emmie de Wita,1,
  2. Friederike Feldmannb,
  3. Jacqueline Cronina,
  4. Robert Jordanc,
  5. Atsushi Okumurad,
  6. Tina Thomasa,
  7. Dana Scottb,
  8. Tomas Cihlarc, and
  9. Heinz Feldmanna
  1. aLaboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  2. bRocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840;
  3. cBiology Department, Gilead Sciences, Foster City, CA 94404;
  4. dCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032
  1. Edited by Michael B. A. Oldstone, Scripps Research Institute, La Jolla, CA, and approved February 7, 2020 (received for review December 16, 2019)

Footnotes

  • ↵1To whom correspondence may be addressed. Email: Emmie.deWit{at}nih.gov.
  • Author contributions: E.d.W., R.J., and H.F. designed research; E.d.W., F.F., J.C., A.O., T.T., and D.S. performed research; T.C. contributed new reagents/analytic tools; E.d.W., A.O., and D.S. analyzed data; E.d.W. and H.F. wrote the paper; and F.F., J.C., R.J., A.O., T.T., D.S., and T.C. read and approved the manuscript.

  • Competing interest statement: The authors affiliated with Gilead Sciences are employees of the company and may own company stock; R.J. holds a patent on the use of remdesivir to treat Filovirus infections. The authors affiliated with NIH have no conflict of interest to report.

  • This article is a PNAS Direct Submission.

  • Data deposition: All data discussed here will be made available to readers upon request.

  • This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1922083117/-/DCSupplemental.

Cited By...

  • 272 Citations
  • 319 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Remdesivir for the Treatment of Covid-19 — Final Report
    John H. Beigel, Kay M. Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, Andre C. Kalil, Elizabeth Hohmann, Helen Y. Chu, Annie Luetkemeyer, Susan Kline, Diego Lopez de Castilla, Robert W. Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F. Patterson, Roger Paredes, Daniel A. Sweeney, William R. Short, Giota Touloumi, David Chien Lye, Norio Ohmagari, Myoung-don Oh, Guillermo M. Ruiz-Palacios, Thomas Benfield, Gerd Fätkenheuer, Mark G. Kortepeter, Robert L. Atmar, C. Buddy Creech, Jens Lundgren, Abdel G. Babiker, Sarah Pett, James D. Neaton, Timothy H. Burgess, Tyler Bonnett, Michelle Green, Mat Makowski, Anu Osinusi, Seema Nayak, H. Clifford Lane
    New England Journal of Medicine 2020 383 19
  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
    Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lu, Huadong Li, Shuzhen Wang, Shunan Ruan, Chengqing Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick G Hayden, Peter W Horby, Bin Cao, Chen Wang
    The Lancet 2020 395 10236
  • Compassionate Use of Remdesivir for Patients with Severe Covid-19
    Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L. Green, François-Xavier Lescure, Emanuele Nicastri, Rentaro Oda, Kikuo Yo, Eugenia Quiros-Roldan, Alex Studemeister, John Redinski, Seema Ahmed, Jorge Bernett, Daniel Chelliah, Danny Chen, Shingo Chihara, Stuart H. Cohen, Jennifer Cunningham, Antonella D’Arminio Monforte, Saad Ismail, Hideaki Kato, Giuseppe Lapadula, Erwan L’Her, Toshitaka Maeno, Sumit Majumder, Marco Massari, Marta Mora-Rillo, Yoshikazu Mutoh, Duc Nguyen, Ewa Verweij, Alexander Zoufaly, Anu O. Osinusi, Adam DeZure, Yang Zhao, Lijie Zhong, Anand Chokkalingam, Emon Elboudwarej, Laura Telep, Leighann Timbs, Ilana Henne, Scott Sellers, Huyen Cao, Susanna K. Tan, Lucinda Winterbourne, Polly Desai, Robertino Mera, Anuj Gaggar, Robert P. Myers, Diana M. Brainard, Richard Childs, Timothy Flanigan
    New England Journal of Medicine 2020 382 24
  • Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
    Waleed Alhazzani, Morten Hylander Møller, Yaseen M. Arabi, Mark Loeb, Michelle Ng Gong, Eddy Fan, Simon Oczkowski, Mitchell M. Levy, Lennie Derde, Amy Dzierba, Bin Du, Michael Aboodi, Hannah Wunsch, Maurizio Cecconi, Younsuck Koh, Daniel S. Chertow, Kathryn Maitland, Fayez Alshamsi, Emilie Belley-Cote, Massimiliano Greco, Matthew Laundy, Jill S. Morgan, Jozef Kesecioglu, Allison McGeer, Leonard Mermel, Manoj J. Mammen, Paul E. Alexander, Amy Arrington, John E. Centofanti, Giuseppe Citerio, Bandar Baw, Ziad A. Memish, Naomi Hammond, Frederick G. Hayden, Laura Evans, Andrew Rhodes
    Intensive Care Medicine 2020 46 5
  • COVID-19 and Cardiovascular Disease
    Kevin J. Clerkin, Justin A. Fried, Jayant Raikhelkar, Gabriel Sayer, Jan M. Griffin, Amirali Masoumi, Sneha S. Jain, Daniel Burkhoff, Deepa Kumaraiah, LeRoy Rabbani, Allan Schwartz, Nir Uriel
    Circulation 2020 141 20
  • SARS-CoV-2 Vaccines: Status Report
    Fatima Amanat, Florian Krammer
    Immunity 2020 52 4
  • Immunology of COVID-19: Current State of the Science
    Nicolas Vabret, Graham J. Britton, Conor Gruber, Samarth Hegde, Joel Kim, Maria Kuksin, Rachel Levantovsky, Louise Malle, Alvaro Moreira, Matthew D. Park, Luisanna Pia, Emma Risson, Miriam Saffern, Bérengère Salomé, Myvizhi Esai Selvan, Matthew P. Spindler, Jessica Tan, Verena van der Heide, Jill K. Gregory, Konstantina Alexandropoulos, Nina Bhardwaj, Brian D. Brown, Benjamin Greenbaum, Zeynep H. Gümüş, Dirk Homann, Amir Horowitz, Alice O. Kamphorst, Maria A. Curotto de Lafaille, Saurabh Mehandru, Miriam Merad, Robert M. Samstein, Manasi Agrawal, Mark Aleynick, Meriem Belabed, Matthew Brown, Maria Casanova-Acebes, Jovani Catalan, Monica Centa, Andrew Charap, Andrew Chan, Steven T. Chen, Jonathan Chung, Cansu Cimen Bozkus, Evan Cody, Francesca Cossarini, Erica Dalla, Nicolas Fernandez, John Grout, Dan Fu Ruan, Pauline Hamon, Etienne Humblin, Divya Jha, Julia Kodysh, Andrew Leader, Matthew Lin, Katherine Lindblad, Daniel Lozano-Ojalvo, Gabrielle Lubitz, Assaf Magen, Zafar Mahmood, Gustavo Martinez-Delgado, Jaime Mateus-Tique, Elliot Meritt, Chang Moon, Justine Noel, Tim O’Donnell, Miyo Ota, Tamar Plitt, Venu Pothula, Jamie Redes, Ivan Reyes Torres, Mark Roberto, Alfonso R. Sanchez-Paulete, Joan Shang, Alessandra Soares Schanoski, Maria Suprun, Michelle Tran, Natalie Vaninov, C. Matthias Wilk, Julio Aguirre-Ghiso, Dusan Bogunovic, Judy Cho, Jeremiah Faith, Emilie Grasset, Peter Heeger, Ephraim Kenigsberg, Florian Krammer, Uri Laserson
    Immunity 2020 52 6
  • Molecular immune pathogenesis and diagnosis of COVID-19
    Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu
    Journal of Pharmaceutical Analysis 2020 10 2
  • Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
    Waleed Alhazzani, Morten Hylander Møller, Yaseen M. Arabi, Mark Loeb, Michelle Ng Gong, Eddy Fan, Simon Oczkowski, Mitchell M. Levy, Lennie Derde, Amy Dzierba, Bin Du, Michael Aboodi, Hannah Wunsch, Maurizio Cecconi, Younsuck Koh, Daniel S. Chertow, Kathryn Maitland, Fayez Alshamsi, Emilie Belley-Cote, Massimiliano Greco, Matthew Laundy, Jill S. Morgan, Jozef Kesecioglu, Allison McGeer, Leonard Mermel, Manoj J. Mammen, Paul E. Alexander, Amy Arrington, John E. Centofanti, Giuseppe Citerio, Bandar Baw, Ziad A. Memish, Naomi Hammond, Frederick G. Hayden, Laura Evans, Andrew Rhodes
    Critical Care Medicine 2020 48 6
  • Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
    Ka-Tim Choy, Alvina Yin-Lam Wong, Prathanporn Kaewpreedee, Sin Fun Sia, Dongdong Chen, Kenrie Pui Yan Hui, Daniel Ka Wing Chu, Michael Chi Wai Chan, Peter Pak-Hang Cheung, Xuhui Huang, Malik Peiris, Hui-Ling Yen
    Antiviral Research 2020 178
  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
    Jason D. Goldman, David C.B. Lye, David S. Hui, Kristen M. Marks, Raffaele Bruno, Rocio Montejano, Christoph D. Spinner, Massimo Galli, Mi-Young Ahn, Ronald G. Nahass, Yao-Shen Chen, Devi SenGupta, Robert H. Hyland, Anu O. Osinusi, Huyen Cao, Christiana Blair, Xuelian Wei, Anuj Gaggar, Diana M. Brainard, William J. Towner, Jose Muñoz, Kathleen M. Mullane, Francisco M. Marty, Karen T. Tashima, George Diaz, Aruna Subramanian
    New England Journal of Medicine 2020 383 19
  • The epidemiology, diagnosis and treatment of COVID-19
    Pan Zhai, Yanbing Ding, Xia Wu, Junke Long, Yanjun Zhong, Yiming Li
    International Journal of Antimicrobial Agents 2020 55 5
  • Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
    Pradip Dashraath, Jing Lin Jeslyn Wong, Mei Xian Karen Lim, Li Min Lim, Sarah Li, Arijit Biswas, Mahesh Choolani, Citra Mattar, Lin Lin Su
    American Journal of Obstetrics and Gynecology 2020 222 6
  • Coronavirus disease 2019 (COVID-19): current status and future perspectives
    Heng Li, Shang-Ming Liu, Xiao-Hua Yu, Shi-Lin Tang, Chao-Ke Tang
    International Journal of Antimicrobial Agents 2020 55 5
  • Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
    Calvin J. Gordon, Egor P. Tchesnokov, Emma Woolner, Jason K. Perry, Joy Y. Feng, Danielle P. Porter, Matthias Götte
    Journal of Biological Chemistry 2020 295 20
  • COVID-19 and the Heart
    Akbarshakh Akhmerov, Eduardo Marbán
    Circulation Research 2020 126 10
  • SARS-CoV-2 and COVID-19: The most important research questions
    Kit-San Yuen, Zi -Wei Ye, Sin-Yee Fung, Chi-Ping Chan, Dong-Yan Jin
    Cell & Bioscience 2020 10 1
  • Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
    Miguel Angel Martinez
    Antimicrobial Agents and Chemotherapy 2020 64 5
  • Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
    Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Maticic, Elisa Cordero, Markus Cornberg, Thomas Berg
    JHEP Reports 2020 2 3
  • Treatment options for COVID-19: The reality and challenges
    Shio-Shin Jean, Ping-Ing Lee, Po-Ren Hsueh
    Journal of Microbiology, Immunology and Infection 2020 53 3
  • Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
    Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall
    ACS Central Science 2020 6 5
  • Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19)
    Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Valery Lavergne, Lindsey Baden, Vincent Chi-Chung Cheng, Kathryn M Edwards, Rajesh Gandhi, William J Muller, John C O’Horo, Shmuel Shoham, M Hassan Murad, Reem A Mustafa, Shahnaz Sultan, Yngve Falck-Ytter
    Clinical Infectious Diseases 2020
  • Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
    Brandi N. Williamson, Friederike Feldmann, Benjamin Schwarz, Kimberly Meade-White, Danielle P. Porter, Jonathan Schulz, Neeltje van Doremalen, Ian Leighton, Claude Kwe Yinda, Lizzette Pérez-Pérez, Atsushi Okumura, Jamie Lovaglio, Patrick W. Hanley, Greg Saturday, Catharine M. Bosio, Sarah Anzick, Kent Barbian, Tomas Cihlar, Craig Martens, Dana P. Scott, Vincent J. Munster, Emmie de Wit
    Nature 2020 585 7824
  • Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review
    Francesco Di Gennaro, Damiano Pizzol, Claudia Marotta, Mario Antunes, Vincenzo Racalbuto, Nicola Veronese, Lee Smith
    International Journal of Environmental Research and Public Health 2020 17 8
  • Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
    Ashleigh Shannon, Nhung Thi-Tuyet Le, Barbara Selisko, Cecilia Eydoux, Karine Alvarez, Jean-Claude Guillemot, Etienne Decroly, Olve Peersen, Francois Ferron, Bruno Canard
    Antiviral Research 2020 178
  • Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
    Federico Alberici, Elisa Delbarba, Chiara Manenti, Laura Econimo, Francesca Valerio, Alessandra Pola, Camilla Maffei, Stefano Possenti, Simone Piva, Nicola Latronico, Emanuele Focà, Francesco Castelli, Paola Gaggia, Ezio Movilli, Sergio Bove, Fabio Malberti, Marco Farina, Martina Bracchi, Ester Maria Costantino, Nicola Bossini, Mario Gaggiotti, Francesco Scolari, Federico Alberici, Elisa Delbarba, Chiara Manenti, Laura Econimo, Francesca Valerio, Alessandra Pola, Camilla Maffei, Stefano Possenti, Nicole Zambetti, Margherita Venturini, Stefania Affatato, Paola Piarulli, Mattia Zappa, Alice Guerini, Francesca Boni, Alberto Mucchetti, Elena Pezzini, Chiara Saccà, Marianna Moscato, Michela Tonoli, Stefano Pasquali, Fabio Viola, Simone Piva, Nicola Latronico, Emanuele Focà, Eugenia Quiros-Roldan, Francesco Castelli, Paola Gaggia, Ezio Movilli, Sergio Bove, Fabio Malberti, Marco Farina, Martina Bracchi, Ester Maria Costantino, Nicola Bossini, Mario Gaggiotti, Francesco Scolari
    Kidney International Reports 2020 5 5
  • Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
    Yu-chen Cao, Qi-xin Deng, Shi-xue Dai
    Travel Medicine and Infectious Disease 2020 35
  • Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
    S. Natoli, V. Oliveira, P. Calabresi, L. F. Maia, A. Pisani
    European Journal of Neurology 2020 27 9
  • Interferon-α2b Treatment for COVID-19
    Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, Zi-Hao Wang, Scott J. Tebbutt, Tobias R. Kollmann, Eleanor N. Fish
    Frontiers in Immunology 2020 11
  • Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
    Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, Boyd L. Yount, Maria L. Agostini, Laura J. Stevens, James D. Chappell, Xiaotao Lu, Tia M. Hughes, Kendra Gully, David R. Martinez, Ariane J. Brown, Rachel L. Graham, Jason K. Perry, Venice Du Pont, Jared Pitts, Bin Ma, Darius Babusis, Eisuke Murakami, Joy Y. Feng, John P. Bilello, Danielle P. Porter, Tomas Cihlar, Ralph S. Baric, Mark R. Denison, Timothy P. Sheahan
    Cell Reports 2020 32 3
  • Current pharmacological treatments for COVID‐19: What's next?
    Cristina Scavone, Simona Brusco, Michele Bertini, Liberata Sportiello, Concetta Rafaniello, Alice Zoccoli, Liberato Berrino, Giorgio Racagni, Francesco Rossi, Annalisa Capuano
    British Journal of Pharmacology 2020 177 21
  • A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
    Maria Romano, Alessia Ruggiero, Flavia Squeglia, Giovanni Maga, Rita Berisio
    Cells 2020 9 5
  • Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
    E. Susan Amirian, Julie K. Levy
    One Health 2020 9
  • Immune-epidemiological parameters of the novel coronavirus – a perspective
    Amene Saghazadeh, Nima Rezaei
    Expert Review of Clinical Immunology 2020 16 5
  • COVID-19: animals, veterinary and zoonotic links
    Ruchi Tiwari, Kuldeep Dhama, Khan Sharun, Mohd. Iqbal Yatoo, Yashpal Singh Malik, Rajendra Singh, Izabela Michalak, Ranjit Sah, D. Katterine Bonilla-Aldana, Alfonso J Rodriguez-Morales
    Veterinary Quarterly 2020 40 1
  • Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks
    Andrew T. Day, David J. Sher, Rebecca C. Lee, John M. Truelson, Larry L. Myers, Baran D. Sumer, Lenka Stankova, Brittny N. Tillman, Randall S. Hughes, Saad A. Khan, Eli A. Gordin
    Oral Oncology 2020 105
  • SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
    Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, Tom Loney, Hanan Al Suwaidi, Ahmed H. Hassan Al-Marzouqi, Afaf Kamal Eldin, Nabeel Alsabeeha, Thomas E. Adrian, Cesare Stefanini, Norbert Nowotny, Alawi Alsheikh-Ali, Abiola C. Senok
    Viruses 2020 12 5
  • Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
    Biswaranjan Paital, Kabita Das, Sarat Kumar Parida
    Science of The Total Environment 2020 728
  • Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
    Jiansheng Huang, Wenliang Song, Hui Huang, Quancai Sun
    Journal of Clinical Medicine 2020 9 4
  • The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
    Longping V. Tse, Rita M. Meganck, Rachel L. Graham, Ralph S. Baric
    Frontiers in Microbiology 2020 11
  • Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
    Shuntong Kang, Wenyao Peng, Yuhao Zhu, Shiyao Lu, Min Zhou, Wei Lin, Wenfang Wu, Shu Huang, Liping Jiang, Xuan Luo, Meichun Deng
    International Journal of Antimicrobial Agents 2020 55 5
  • Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
    Kathleen Chiotos, Molly Hayes, David W Kimberlin, Sarah B Jones, Scott H James, Swetha G Pinninti, April Yarbrough, Mark J Abzug, Christine E MacBrayne, Vijaya L Soma, Daniel E Dulek, Surabhi B Vora, Alpana Waghmare, Joshua Wolf, Rosemary Olivero, Steven Grapentine, Rachel L Wattier, Laura Bio, Shane J Cross, Nicholas O Dillman, Kevin J Downes, Kathryn Timberlake, Jennifer Young, Rachel C Orscheln, Pranita D Tamma, Hayden T Schwenk, Philip Zachariah, Margaret Aldrich, David L Goldman, Helen E Groves, Gabriella S Lamb, Alison C Tribble, Adam L Hersh, Emily A Thorell, Mark R Denison, Adam J Ratner, Jason G Newland, Mari M Nakamura
    Journal of the Pediatric Infectious Diseases Society 2020
  • Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19
    Sarah C.J. Jorgensen, Razieh Kebriaei, Linda D. Dresser
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2020 40 7
  • Therapeutic strategies for critically ill patients with COVID-19
    Lei Li, Ranran Li, Zhixiong Wu, Xianghong Yang, Mingyan Zhao, Jiao Liu, Dechang Chen
    Annals of Intensive Care 2020 10 1
  • Remdesivir in covid-19
    Robin E Ferner, Jeffrey K Aronson
    BMJ 2020
  • Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?
    James Segars, Quinton Katler, Dana B. McQueen, Alexander Kotlyar, Tanya Glenn, Zac Knight, Eve C. Feinberg, Hugh S. Taylor, James P. Toner, Jennifer F. Kawwass
    Fertility and Sterility 2020 113 6
  • Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
    Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Anoop Misra
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020 14 4
  • Nurture to nature via COVID-19, a self-regenerating environmental strategy of environment in global context
    Biswaranjan Paital
    Science of The Total Environment 2020 729
  • An overview of coronaviruses including the SARS-2 coronavirus – Molecular biology, epidemiology and clinical implications
    Dinesh Kaul
    Current Medicine Research and Practice 2020 10 2
  • COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
    Yang Song, Min Zhang, Ling Yin, Kunkun Wang, Yiyi Zhou, Mi Zhou, Yun Lu
    International Journal of Antimicrobial Agents 2020 56 2
  • Liver injury in COVID‐19: The current evidence
    Saleh A Alqahtani, Jörn M Schattenberg
    United European Gastroenterology Journal 2020 8 5
  • Coronaviruses and SARS-CoV-2: A Brief Overview
    Stephan Ludwig, Alexander Zarbock
    Anesthesia & Analgesia 2020 131 1
  • Déjà vu: Stimulating open drug discovery for SARS-CoV-2
    Sean Ekins, Melina Mottin, Paulo R.P.S. Ramos, Bruna K.P. Sousa, Bruno Junior Neves, Daniel H. Foil, Kimberley M. Zorn, Rodolpho C. Braga, Megan Coffee, Christopher Southan, Ana C. Puhl, Carolina Horta Andrade
    Drug Discovery Today 2020 25 5
  • A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29
    Steve P.H. Alexander, Jane F. Armstrong, Anthony P. Davenport, Jamie A. Davies, Elena Faccenda, Simon D. Harding, Francesca Levi‐Schaffer, Janet J. Maguire, Adam J. Pawson, Christopher Southan, Michael Spedding
    British Journal of Pharmacology 2020 177 21
  • COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
    Giuseppe Magro
    Virus Research 2020 286
  • ISUOG Interim Guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium: information for healthcare professionals – an update
    L. . C. Poon, H. Yang, S. Dumont, J. C. S. Lee, J. A. Copel, L. Danneels, A. Wright, F. Da Silva Costa, T. Y. Leung, Y. Zhang, D. Chen, F. Prefumo
    Ultrasound in Obstetrics & Gynecology 2020 55 6
  • 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice
    Athri D. Rathnayake, Jian Zheng, Yunjeong Kim, Krishani Dinali Perera, Samantha Mackin, David K. Meyerholz, Maithri M. Kashipathy, Kevin P. Battaile, Scott Lovell, Stanley Perlman, William C. Groutas, Kyeong-Ok Chang
    Science Translational Medicine 2020 12 557
  • Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)
    Dave L. Dixon, Benjamin W. Van Tassell, Alessandra Vecchié, Aldo Bonaventura, Azita H. Talasaz, Hessam Kakavand, Fabrizio DʼAscenzo, Antonio Perciaccante, Davide Castagno, Enrico Ammirati, Giuseppe Biondi-Zoccai, Michael P. Stevens, Antonio Abbate
    Journal of Cardiovascular Pharmacology 2020 75 5
  • Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
    Fran Robson, Khadija Shahed Khan, Thi Khanh Le, Clément Paris, Sinem Demirbag, Peter Barfuss, Palma Rocchi, Wai-Lung Ng
    Molecular Cell 2020 79 5
  • SARS-CoV-2 and COVID-19: From the Bench to the Bedside
    Stefano Romagnoli, Adriano Peris, A. Raffaele De Gaudio, Pierangelo Geppetti
    Physiological Reviews 2020 100 4
  • A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
    Chengyuan Liang, Lei Tian, Yuzhi Liu, Nan Hui, Guaiping Qiao, Han Li, Zhenfeng Shi, Yonghong Tang, Dezhu Zhang, Xiaolin Xie, Xu Zhao
    European Journal of Medicinal Chemistry 2020 201
  • Animal models for emerging coronavirus: progress and new insights
    Lunzhi Yuan, Qiyi Tang, Tong Cheng, Ningshao Xia
    Emerging Microbes & Infections 2020 9 1
  • Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit
    Duxin Sun
    The AAPS Journal 2020 22 4
  • A current review of COVID-19 for the cardiovascular specialist
    Joshua P. Lang, Xiaowen Wang, Filipe A. Moura, Hasan K. Siddiqi, David A. Morrow, Erin A. Bohula
    American Heart Journal 2020 226
  • The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications
    Rami A. Ballout, Dmitri Sviridov, Michael I. Bukrinsky, Alan T. Remaley
    The FASEB Journal 2020 34 6
  • COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
    Kacper Lechowicz, Sylwester Drożdżal, Filip Machaj, Jakub Rosik, Bartosz Szostak, Małgorzata Zegan-Barańska, Jowita Biernawska, Wojciech Dabrowski, Iwona Rotter, Katarzyna Kotfis
    Journal of Clinical Medicine 2020 9 6
  • Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
    Yeming Wang, Fei Zhou, Dingyu Zhang, Jianping Zhao, Ronghui Du, Yi Hu, Zhenshun Cheng, Ling Gao, Yang Jin, Guangwei Luo, Shouzhi Fu, Qiaofa Lu, Guanhua Du, Ke Wang, Yang Lu, Guohui Fan, Yi Zhang, Ying Liu, Shunan Ruan, Wen Liu, Thomas Jaki, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang
    Trials 2020 21 1
  • Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
    Sebastiano Cicco, Gerolamo Cicco, Vito Racanelli, Angelo Vacca
    Mediators of Inflammation 2020 2020
  • Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
    Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay
    Frontiers in Immunology 2020 11
  • Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
    Kumari G. Lokugamage, Adam Hage, Maren de Vries, Ana M. Valero-Jimenez, Craig Schindewolf, Meike Dittmann, Ricardo Rajsbaum, Vineet D. Menachery, Bryan R. G. Williams
    Journal of Virology 2020 94 23
  • Treatment Considerations for COVID-19
    Prakhar Vijayvargiya, Zerelda Esquer Garrigos, Natalia E. Castillo Almeida, Pooja R. Gurram, Ryan W. Stevens, Raymund R. Razonable
    Mayo Clinic Proceedings 2020 95 7
  • COVID-19 infection: the China and Italy perspectives
    Jun Chen, Hongzhou Lu, Gerry Melino, Stefania Boccia, Mauro Piacentini, Walter Ricciardi, Ying Wang, Yufang Shi, Tongyu Zhu
    Cell Death & Disease 2020 11 6
  • COVID-19: A Brief Overview of the Discovery Clinical Trial
    Jean Jacques Vanden Eynde
    Pharmaceuticals 2020 13 4
  • Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review
    Alfredo Pennica, Giulia Conforti, Francesca Falangone, Antonio Martocchia, Laura Tafaro, Alberto Sentimentale, Valentina Marini, Aldo Pezzuto, Valerio Spuntarelli, Paolo Martelletti
    SN Comprehensive Clinical Medicine 2020 2 6
  • Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects
    Rita Humeniuk, Anita Mathias, Huyen Cao, Anu Osinusi, Gong Shen, Estelle Chng, John Ling, Amanda Vu, Polina German
    Clinical and Translational Science 2020
  • A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States
    Bradley Sanville, Rebecca Corbett, Wesley Pidcock, Kaitlyn Hardin, Christian Sebat, Minh-Vu Nguyen, George R Thompson, Angela Haczku, Michael Schivo, Stuart Cohen
    Clinical Infectious Diseases 2020 71 16
  • COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
    Anshumali Mittal, Kavyashree Manjunath, Rajesh Kumar Ranjan, Sandeep Kaushik, Sujeet Kumar, Vikash Verma, Tom C. Hobman
    PLOS Pathogens 2020 16 8
  • Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review
    Yuanqiang Yu, Pingyang Chen
    Frontiers in Pediatrics 2020 8
  • FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
    Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, Filip Machaj, Katarzyna Kotfis, Saeid Ghavami, Marek J. Łos
    Drug Resistance Updates 2020 53
  • Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
    Hsin-I Shih, Chi-Jung Wu, Yi-Fang Tu, Chia-Yu Chi
    Biomedical Journal 2020 43 4
  • Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
    Denise J. Wooding, Horacio Bach
    Clinical Microbiology and Infection 2020 26 10
  • nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics
    Md. Tanvir Kabir, Md. Sahab Uddin, Md. Farhad Hossain, Jawaher A. Abdulhakim, Md. Asraful Alam, Ghulam Md Ashraf, Simona G. Bungau, May N. Bin-Jumah, Mohamed M. Abdel-Daim, Lotfi Aleya
    Frontiers in Cell and Developmental Biology 2020 8
  • A global treatments for coronaviruses including COVID‐19
    Bahman Yousefi, Saeid Valizadeh, Hadi Ghaffari, Azadeh Vahedi, Mohsen Karbalaei, Majid Eslami
    Journal of Cellular Physiology 2020 235 12
  • Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
    M. Bassetti, D.R. Giacobbe, S. Aliberti, E. Barisione, S. Centanni, F.G. De Rosa, F. Di Marco, A. Gori, G. Granata, M. Mikulska, N. Petrosillo, L. Richeldi, P. Santus, C. Tascini, A. Vena, P. Viale, F. Blasi
    Clinical Microbiology and Infection 2020 26 7
  • Drug repurposing against COVID-19: focus on anticancer agents
    Gennaro Ciliberto, Rita Mancini, Marco G. Paggi
    Journal of Experimental & Clinical Cancer Research 2020 39 1
  • Drug repurposing approach to fight COVID-19
    Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar, Raj Kumar Singh
    Pharmacological Reports 2020 72 6
  • Remdesivir and its antiviral activity against COVID-19: A systematic review
    Andri Frediansyah, Firzan Nainu, Kuldeep Dhama, Mudatsir Mudatsir, Harapan Harapan
    Clinical Epidemiology and Global Health 2021 9
  • Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
    Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, Peter Dube, Xiujun Zhang, Yanmei Hu, Naoya Kitamura, Brett Hurst, Bart Tarbet, Michael Thomas Marty, Antonios Kolocouris, Yan Xiang, Yu Chen, Jun Wang
    Science Advances 2020 6 50
  • The liver in times of COVID-19: What hepatologists should know
    Ezequiel Ridruejo, Alejandro Soza
    Annals of Hepatology 2020 19 4
  • COVID-19 Therapeutic Options Under Investigation
    Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Eid, Hassan Zaraket
    Frontiers in Pharmacology 2020 11
  • Drug Discovery Strategies for SARS-CoV-2
    Zeenat A. Shyr, Kirill Gorshkov, Catherine Z. Chen, Wei Zheng
    Journal of Pharmacology and Experimental Therapeutics 2020 375 1
  • Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
    Ujjwal Neogi, Kyle J. Hill, Anoop T Ambikan, Xiao Heng, Thomas P. Quinn, Siddappa N. Byrareddy, Anders Sönnerborg, Stefan G. Sarafianos, Kamal Singh
    Pathogens 2020 9 5
  • Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
    Liise-anne Pirofski, Arturo Casadevall, Thomas E. Morrison, Danielle A. Garsin
    mBio 2020 11 4
  • Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2
    Rudramani Pokhrel, Prem Chapagain, Jessica Siltberg-Liberles
    Journal of Medical Microbiology 2020 69 6
  • Special features of SARS-CoV-2 in daily practice
    Ioannis A Charitos, Andrea Ballini, Lucrezia Bottalico, Stefania Cantore, Pier Carmine Passarelli, Francesco Inchingolo, Antonio D'Addona, Luigi Santacroce
    World Journal of Clinical Cases 2020 8 18
  • COVID‐19: A review of therapeutics under investigation
    James C. Crosby, Matthew A. Heimann, Samuel L. Burleson, Brendan C. Anzalone, Jonathan F. Swanson, Douglas W. Wallace, Christopher J. Greene
    Journal of the American College of Emergency Physicians Open 2020 1 3
  • Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
    Miranda Davies, Vicki Osborne, Samantha Lane, Debabrata Roy, Sandeep Dhanda, Alison Evans, Saad Shakir
    Drug Safety 2020 43 7
  • Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
    Sirle Saul, Shirit Einav
    ACS Infectious Diseases 2020 6 9
  • Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
    Jun He, Lijun Hu, Xiaojun Huang, Chenran Wang, Zhimin Zhang, Ying Wang, Dongmei Zhang, Wencai Ye
    International Journal of Antimicrobial Agents 2020 56 2
  • RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target
    Yanyan Wang, Varada Anirudhan, Ruikun Du, Qinghua Cui, Lijun Rong
    Journal of Medical Virology 2021 93 1
  • The Rationale for Potential Pharmacotherapy of COVID-19
    Maha Saber-Ayad, Mohamed A. Saleh, Eman Abu-Gharbieh
    Pharmaceuticals 2020 13 5
  • Urgent reconsideration of lung edema as a preventable outcome in COVID-19: inhibition of TRPV4 represents a promising and feasible approach
    Wolfgang M. Kuebler, Sven-Eric Jordt, Wolfgang B. Liedtke
    American Journal of Physiology-Lung Cellular and Molecular Physiology 2020 318 6
  • <p>A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19</p>
    Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati
    Drug Design, Development and Therapy 2020 Volume 14
  • Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
    Igor de Andrade Santos, Victória Riquena Grosche, Fernando Rodrigues Goulart Bergamini, Robinson Sabino-Silva, Ana Carolina Gomes Jardim
    Frontiers in Microbiology 2020 11
  • Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)
    Keykavous Parang, Naglaa Salem El-Sayed, Assad J. Kazeminy, Rakesh K. Tiwari
    Molecules 2020 25 10
  • Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase
    Mohammad Mahdi Nejadi Babadaei, Anwarul Hasan, Yasaman Vahdani, Samir Haj Bloukh, Majid Sharifi, Ehsan Kachooei, Setareh Haghighat, Mojtaba Falahati
    Journal of Biomolecular Structure and Dynamics 2020
  • Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection
    Jasvinder Singh Bhatti, Gurjit Kaur Bhatti, Naina Khullar, Arubala P. Reddy, P. Hemachandra Reddy
    Molecular Neurobiology 2020 57 11
  • A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
    Sabari Nath Neerukonda, Upendra Katneni
    Pathogens 2020 9 6
  • Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
    Madalina Elena Carter-Timofte, Sofie Eg Jørgensen, Mette Ratzer Freytag, Michelle Mølgaard Thomsen, Nanna-Sophie Brinck Andersen, Ali Al-Mousawi, Alon Schneider Hait, Trine H. Mogensen
    Frontiers in Immunology 2020 11
  • Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?
    Sangiliyandi Gurunathan, Muhammad Qasim, Youngsok Choi, Jeong Tae Do, Chankyu Park, Kwonho Hong, Jin-Hoi Kim, Hyuk Song
    Nanomaterials 2020 10 9
  • Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
    Mekonnen Sisay
    Frontiers in Pharmacology 2020 11
  • Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
    Arif Jamal Siddiqui, Sadaf Jahan, Syed Amir Ashraf, Mousa Alreshidi, Mohammad Saquib Ashraf, Mitesh Patel, Mejdi Snoussi, Ritu Singh, Mohd Adnan
    Journal of Biomolecular Structure and Dynamics 2020
  • Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm
    Eddie W. Fakhouri, Stephen J. Peterson, Janish Kothari, Ragin Alex, Joseph I. Shapiro, Nader G. Abraham
    Antioxidants 2020 9 7
  • Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease
    M. Nazmul Hoque, Abed Chaudhury, Md Abdul Mannan Akanda, M. Anwar Hossain, Md Tofazzal Islam
    PeerJ 2020 8
  • Interim Guidelines on Antiviral Therapy for COVID-19
    Sun Bean Kim, Kyungmin Huh, Jung Yeon Heo, Eun-Jeong Joo, Youn Jeong Kim, Won Suk Choi, Yae-Jean Kim, Yu Bin Seo, Young Kyung Yoon, Nam Su Ku, Su Jin Jeong, Sung-Han Kim, Kyong Ran Peck, Joon Sup Yeom
    Infection & Chemotherapy 2020 52 2
  • Literature-based review of the drugs used for the treatment of COVID-19
    Meda Venkatasubbaiah, P. Dwarakanadha Reddy, Suggala V. Satyanarayana
    Current Medicine Research and Practice 2020 10 3
  • Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery
    Ariane Sternberg, Dwight L. McKee, Cord Naujokat
    Current Topics in Medicinal Chemistry 2020 20 16
  • Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis
    Yasmeen Junejo, Mehmet Ozaslan, Muhamad Safdar, Rozhgar A. Khailany, SaifUr Rehman, Wasim Yousaf, Musarrat Abbas Khan
    Gene Reports 2020 20
  • Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
    Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, Boyd L. Yount, Maria L. Agostini, Laura J. Stevens, James D. Chappell, Xiaotao Lu, Tia M. Hughes, Kendra Gully, David Martinez, Ariane J. Brown, Rachel L. Graham, Jason K. Perry, Venice Du Pont, Jared Pitts, Bin Ma, Darius Babusis, Eisuke Murakami, Joy Y. Feng, John P. Bilello, Danielle Porter, Tomas Cihlar, Ralph S. Baric, Mark R. Denison, Timothy P. Sheahan
    SSRN Electronic Journal 2020
  • Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
    Jennifer Santos, Stephanie Brierley, Mohit J. Gandhi, Michael A. Cohen, Phillip C. Moschella, Arwen B. L. Declan
    Viruses 2020 12 7
  • SARS-CoV-2 Infection and the Newborn
    Fahri Ovalı
    Frontiers in Pediatrics 2020 8
  • Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
    Rui-fang Zhu, Yu-lu Gao, Sue-Ho Robert, Jin-ping Gao, Shi-gui Yang, Chang-tai Zhu
    Journal of Translational Medicine 2020 18 1
  • Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
    Simin Seyedpour, Behzad Khodaei, Amir H. Loghman, Nasrin Seyedpour, Misagh F. Kisomi, Maryam Balibegloo, Sasan S. Nezamabadi, Bahareh Gholami, Amene Saghazadeh, Nima Rezaei
    Journal of Cellular Physiology 2020
  • Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
    Egor P. Tchesnokov, Calvin J. Gordon, Emma Woolner, Dana Kocinkova, Jason K. Perry, Joy Y. Feng, Danielle P. Porter, Matthias Götte
    Journal of Biological Chemistry 2020 295 47
  • Drugs against SARS‐CoV ‐2: What do we know about their mode of action?
    Coralie Valle, Baptiste Martin, Franck Touret, Ashleigh Shannon, Bruno Canard, Jean‐Claude Guillemot, Bruno Coutard, Etienne Decroly
    Reviews in Medical Virology 2020 30 6
  • Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
    S. Wesley Long, Randall J. Olsen, Paul A. Christensen, David W. Bernard, James J. Davis, Maulik Shukla, Marcus Nguyen, Matthew Ojeda Saavedra, Prasanti Yerramilli, Layne Pruitt, Sishir Subedi, Hung-Che Kuo, Heather Hendrickson, Ghazaleh Eskandari, Hoang A. T. Nguyen, J. Hunter Long, Muthiah Kumaraswami, Jule Goike, Daniel Boutz, Jimmy Gollihar, Jason S. McLellan, Chia-Wei Chou, Kamyab Javanmardi, Ilya J. Finkelstein, James M. Musser, Robert A. Bonomo
    mBio 2020 11 6
  • Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China
    Xiaoqi Pan, Lan Dong, Lian Yang, Dayi Chen, Cheng Peng
    Virus Research 2020 286
  • Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study
    Stefania Mazzini, Loana Musso, Sabrina Dallavalle, Roberto Artali
    Molecules 2020 25 16
  • Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
    Ghada Algwaiz, Mahmoud Aljurf, Mickey Koh, Mary M. Horowitz, Per Ljungman, Daniel Weisdorf, Wael Saber, Yoshihisa Kodera, Jeff Szer, Dunia Jawdat, William A. Wood, Ruta Brazauskas, Leslie Lehmann, Marcelo C. Pasquini, Adriana Seber, Pei Hua Lu, Yoshiko Atsuta, Marcie Riches, Miguel-Angel Perales, Nina Worel, Shinichiro Okamoto, Alok Srivastava, Roy F. Chemaly, Catherine Cordonnier, Christopher E. Dandoy, John R. Wingard, Mohamed A. Kharfan-Dabaja, Mehdi Hamadani, Navneet S. Majhail, Alpana A. Waghmare, Nelson Chao, Nicolaus Kröger, Bronwen Shaw, Mohamad Mohty, Dietger Niederwieser, Hildegard Greinix, Shahrukh K. Hashmi
    Biology of Blood and Marrow Transplantation 2020 26 12
  • SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
    José Adão Carvalho Nascimento Junior, Anamaria Mendonça Santos, Lucindo José Quintans-Júnior, Cristiani Isabel Banderó Walker, Lysandro Pinto Borges, Mairim Russo Serafini
    Expert Opinion on Therapeutic Patents 2020 30 8
  • Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics
    Hariharan Sivaraman, Shi Yin Er, Yeu Khai Choong, Edem Gavor, J. Sivaraman
    Annual Review of Pharmacology and Toxicology 2021 61 1
  • Systematic review of COVID-19 related myocarditis: Insights on management and outcome
    Khalid Sawalha, Mohammed Abozenah, Anis John Kadado, Ayman Battisha, Mohammad Al-Akchar, Colby Salerno, Jaime Hernandez-Montfort, Ashequl M. Islam
    Cardiovascular Revascularization Medicine 2020
  • Systemic In Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server
    Chi Xu, Zunhui Ke, Chuandong Liu, Zhihao Wang, Denghui Liu, Lei Zhang, Jingning Wang, Wenjun He, Zhimeng Xu, Yanqing Li, Yanan Yang, Zhaowei Huang, Panjing Lv, Xin Wang, Dali Han, Yan Li, Nan Qiao, Bing Liu
    Journal of Chemical Information and Modeling 2020 60 12
  • Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
    Arif Hussain, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Muhammad E.H. Chowdhury, Majid Sharifi, Setareh Haghighat, Mojtaba Falahati
    Biomedicine & Pharmacotherapy 2020 130
  • A Generalized Overview of SARS-CoV-2: Where Does the Current Knowledge Stand?
    Hiya Islam, Ahsab Rahman, Jaasia Masud, Dipita Saha Shweta, Yusha Araf, Md. Asad Ullah, Syed Muktadir Al Sium, Bishajit Sarkar
    Electronic Journal of General Medicine 2020 17 6
  • A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
    Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, Jianying Liu, Ping Ren, Mini Balakrishnan, Tomas Cihlar, Chien-Te K. Tseng, Shinji Makino, Vineet D. Menachery, John P. Bilello, Pei-Yong Shi
    Nature Communications 2020 11 1
  • Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center
    Jennifer A. McCoy, William R. Short, Sindhu K. Srinivas, Lisa D. Levine, Adi Hirshberg
    American Journal of Obstetrics & Gynecology MFM 2020 2 3
  • Drug treatment of coronavirus disease 2019 (COVID-19) in China.
    Zhe Jin, Jing-Yi Liu, Rang Feng, Lu Ji, Zi-Li Jin, Hai-Bo Li
    European Journal of Pharmacology 2020 883
  • Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
    Alessandro Favilli, Marta Mattei Gentili, Francesca Raspa, Irene Giardina, Fabio Parazzini, Amerigo Vitagliano, Anna V. Borisova, Sandro Gerli
    The Journal of Maternal-Fetal & Neonatal Medicine 2020
  • Establishment of an African green monkey model for COVID-19 and protection against re-infection
    Courtney Woolsey, Viktoriya Borisevich, Abhishek N. Prasad, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, John C. Heymann, Stephanie L. Foster, Corri B. Levine, Liana Medina, Kevin Melody, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert, Robert W. Cross
    Nature Immunology 2021 22 1
  • Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of IK(M) or IK(DR) and in the Stimulation of IMEP
    Wei-Ting Chang, Ping-Yen Liu, Zi-Han Gao, Shih-Wei Lee, Wen-Kai Lee, Sheng-Nan Wu
    Frontiers in Pharmacology 2020 11
  • Lung tissue distribution of drugs as a key factor for COVID‐19 treatment
    Yan Wang, Lei Chen
    British Journal of Pharmacology 2020 177 21
  • PNAS and the pandemic
    May R. Berenbaum
    Proceedings of the National Academy of Sciences 2020 117 18
  • Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019
    Margaux Louchet, Jeanne Sibiude, Gilles Peytavin, Olivier Picone, Jean-Marc Tréluyer, Laurent Mandelbrot
    American Journal of Obstetrics & Gynecology MFM 2020 2 3
  • Possible therapeutic agents for COVID-19: a comprehensive review
    Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay, Mohamed Gomaa Kamel
    Expert Review of Anti-infective Therapy 2020 18 10
  • Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
    Michael K. Lo, César G. Albariño, Jason K. Perry, Silvia Chang, Egor P. Tchesnokov, Lisa Guerrero, Ayan Chakrabarti, Punya Shrivastava-Ranjan, Payel Chatterjee, Laura K. McMullan, Ross Martin, Robert Jordan, Matthias Götte, Joel M. Montgomery, Stuart T. Nichol, Mike Flint, Danielle Porter, Christina F. Spiropoulou
    Proceedings of the National Academy of Sciences 2020 117 43
  • Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses
    Eva Konkolova, Milan Dejmek, Hubert Hřebabecký, Michal Šála, Jiří Böserle, Radim Nencka, Evzen Boura
    Antiviral Research 2020 182
  • SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
    Giuseppe Magro
    Travel Medicine and Infectious Disease 2020 37
  • SARS-CoV-2/COVID-19
    Marcin F. Osuchowski, Federico Aletti, Jean-Marc Cavaillon, Stefanie B. Flohé, Evangelos J. Giamarellos-Bourboulis, Markus Huber-Lang, Borna Relja, Tomasz Skirecki, Andrea Szabó, Marc Maegele
    Shock 2020 Publish Ahead of Print
  • Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors
    Alice Romeo, Federico Iacovelli, Mattia Falconi
    Virus Research 2020 286
  • The Lord of the NanoRings: Cyclodextrins and the battle against SARS-CoV-2
    Pablo F. Garrido, Martín Calvelo, Alexandre Blanco-González, Uxía Veleiro, Fabián Suárez, Daniel Conde, Alfonso Cabezón, Ángel Piñeiro, Rebeca Garcia-Fandino
    International Journal of Pharmaceutics 2020 588
  • Uncovering the chemistry of C–C bond formation in C-nucleoside biosynthesis: crystal structure of a C-glycoside synthase/PRPP complex
    Sisi Gao, Ashish Radadiya, Wenbo Li, Huanting Liu, Wen Zhu, Valérie de Crécy-Lagard, Nigel G. J. Richards, James H. Naismith
    Chemical Communications 2020 56 55
  • Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
    Benedikt Preckel, Marcus J. Schultz, Alexander P. Vlaar, Abraham H. Hulst, Jeroen Hermanides, Menno D. de Jong, Wolfgang S. Schlack, Markus F. Stevens, Robert P. Weenink, Markus W. Hollmann
    Journal of Clinical Medicine 2020 9 5
  • <p>Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen</p>
    Mahtabalsadat Mirjalili, Mojtaba Shafiekhani, Afsaneh Vazin
    Therapeutics and Clinical Risk Management 2020 Volume 16
  • A Narrative Review of Emerging Therapeutics for COVID-19
    Van C. Willis, Yull Arriaga, Dilhan Weeraratne, Fredy Reyes, Gretchen P. Jackson
    Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2020 4 6
  • Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection
    Gayathri Krishna, Vinod Soman Pillai, Mohanan Valiya Veettil
    European Journal of Pharmacology 2020 885
  • Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines
    Rajnish Kumar, Janmejai Kumar Srivastava, Rachana Singh, Mohammed Haris Siddiqui, Rasha A. Mansouri, Jawaher A. Abdulhakim, May N. Bin-Jumah, Saad Alkahtani, Mohamed M. Abdel-Daim, Md. Sahab Uddin
    Frontiers in Pharmacology 2020 11
  • COVID-19 Pandemic: Time to Revive the Cyclophilin Inhibitor Alisporivir
    Jean-Michel Pawlotsky
    Clinical Infectious Diseases 2020 71 16
  • Cancer therapy and treatments during COVID-19 era
    Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Saverio Candido, Massimo Libra, Kvin Lerpiriyapong, Lucio Cocco, Giulia Ramazzotti, Stefano Ratti, Matilde Y. Follo, Alberto M. Martelli, William L. Blalock, Manuela Piazzi, Giuseppe Montalto, Melchiorre Cervello, Monica Notarbartolo, Jorg Basecke, James A. McCubrey
    Advances in Biological Regulation 2020 77
  • CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2
    Amit Kumar Gupta, Md. Shoaib Khan, Shubham Choudhury, Adhip Mukhopadhyay, Sakshi, Amber Rastogi, Anamika Thakur, Pallawi Kumari, Manmeet Kaur, Shalu, Chanchal Saini, Vandna Sapehia, Barkha, Pradeep Kumar Patel, Kailash T. Bhamare, Manoj Kumar
    Frontiers in Microbiology 2020 11
  • El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo
    J. Reina
    Vacunas 2020 21 1
  • Evaluation of Current Therapies for COVID-19 Treatment
    Atin Sethi, Horacio Bach
    Microorganisms 2020 8 8
  • Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
    Claudio Ortolani, Elide A. Pastorello
    Clinical and Molecular Allergy 2020 18 1
  • Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19
    Mohammed M. Alvi, Sowmya Sivasankaran, Mahima Singh
    Journal of Drug Targeting 2020 28 7-8
  • Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update
    Puja Kumari, Kajal Rawat, Lekha Saha
    Current Pharmacology Reports 2020 6 5
  • Remdesivir against COVID-19 and Other Viral Diseases
    Jakob J. Malin, Isabelle Suárez, Vanessa Priesner, Gerd Fätkenheuer, Jan Rybniker
    Clinical Microbiology Reviews 2020 34 1
  • Zoonotic Diseases: Etiology, Impact, and Control
    Md. Tanvir Rahman, Md. Abdus Sobur, Md. Saiful Islam, Samina Ievy, Md. Jannat Hossain, Mohamed E. El Zowalaty, AMM Taufiquer Rahman, Hossam M. Ashour
    Microorganisms 2020 8 9
  • Remdesivir: A beacon of hope from Ebola virus disease to COVID ‐19
    Ali Nili, Abolfazl Farbod, Afarin Neishabouri, Mohammad Mozafarihashjin, Soheil Tavakolpour, Hamidreza Mahmoudi
    Reviews in Medical Virology 2020 30 6
  • A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
    Dawid Maciorowski, Samir Z. El Idrissi, Yash Gupta, Brian J. Medernach, Michael B. Burns, Daniel P. Becker, Ravi Durvasula, Prakasha Kempaiah
    SLAS DISCOVERY: Advancing the Science of Drug Discovery 2020 25 10
  • A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
    Alexander Simonis, Sebastian J Theobald, Gerd Fätkenheuer, Jan Rybniker, Jakob J Malin
    EMBO Molecular Medicine 2021 13 1
  • An Urgent Need for “Common Cold Units” to Study COVID-19
    Scott B. Halstead
    The American Journal of Tropical Medicine and Hygiene 2020 102 6
  • COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase
    Scott B. Halstead, Ramesh Akkina
    Frontiers in Immunology 2020 11
  • COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission
    Mulugeta Kiros, Henok Andualem, Teklehaimanot Kiros, Wasihun Hailemichael, Sisay Getu, Alene Geteneh, Derbie Alemu, Woldaregay Erku Abegaz
    Virology Journal 2020 17 1
  • Clinical Trials of Repurposed Antivirals for SARS-CoV-2
    Miguel Angel Martinez
    Antimicrobial Agents and Chemotherapy 2020 64 9
  • Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
    Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B. Nair, Pran Kishore Deb
    Frontiers in Molecular Biosciences 2020 7
  • Computational screening for potential drug candidates against the SARS-CoV-2 main protease
    Bruno Silva Andrade, Preetam Ghosh, Debmalya Barh, Sandeep Tiwari, Raner José Santana Silva, Wagner Rodrigues de Assis Soares, Tarcisio Silva Melo, Andria Santos Freitas, Patrícia González-Grande, Lucas Sousa Palmeira, Luiz Carlos Junior Alcantara, Marta Giovanetti, Aristóteles Góes-Neto, Vasco Ariston de Carvalho Azevedo
    F1000Research 2020 9
  • Coronaviren: von der banalen Erkältung zum schweren Lungenversagen
    F. Hufert, M. Spiegel
    Monatsschrift Kinderheilkunde 2020 168 6
  • Coronavirus Disease (COVID-19) Pandemic: A Race Against Time
    Amit K. Banerjee, Neelima Arora
    Current Topics in Medicinal Chemistry 2020 20 16
  • Current Prevention of COVID-19: Natural Products and Herbal Medicine
    Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang, Jia-xu Chen
    Frontiers in Pharmacology 2020 11
  • Efficacy and safety of remdesivir in hospitalized Covid‐19 patients: Systematic review and meta‐analysis including network meta‐analysis
    Hozaifa Khalil Elsawah, Mohamed Ahmed Elsokary, Mahmoud Samy Abdallah, Ahmed Hanei ElShafie
    Reviews in Medical Virology 2020
  • Emerging Therapeutic Modalities against COVID-19
    Shipra Malik, Anisha Gupta, Xiaobo Zhong, Theodore P. Rasmussen, Jose E. Manautou, Raman Bahal
    Pharmaceuticals 2020 13 8
  • Immunosuppression in a lung transplant recipient with COVID-19? Lessons from an early case
    J. Raëth, A. Tomio, A. Eugene, A. Mouffak, M. Durand, R. Hamidfar, C. Pison, H. Pluchart, A.L. Mounayar
    Respiratory Medicine and Research 2020 78
  • Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials
    Alexandra Abrams-Downey, Joseph Saabiye, Monica Vidaurrazaga
    European Urology Focus 2020 6 5
  • Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
    Ahmed Mostafa, Ahmed Kandeil, Mahmoud Shehata, Rabeh El Shesheny, Abdallah M. Samy, Ghazi Kayali, Mohamed A. Ali
    Microorganisms 2020 8 7
  • Potential inhibitors for the novel coronavirus (SARS-CoV-2)
    Yanqiang Han, Zhilong Wang, Jiahao Ren, Zhiyun Wei, Jinjin Li
    Briefings in Bioinformatics 2020
  • Remdesivir—Bringing Hope for COVID-19 Treatment
    Naser F. Al-Tannak, Ladislav Novotny, Adel Alhunayan
    Scientia Pharmaceutica 2020 88 2
  • SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
    Guilherme Antonio de Souza Silva, Suéllen Pedrosa da Silva, Marcos Aurélio Santos da Costa, Abdênego Rodrigues da Silva, Robson Raion de Vasconcelos Alves, Fernanda das Chagas Ângelo Mendes Tenório, Alanne Rayssa da Silva Melo, Antonio Carlos de Freitas, Cristiane Moutinho Lagos de Melo
    Journal of Gynecology Obstetrics and Human Reproduction 2020 49 10
  • Should we be concerned about COVID‐19 with nonhuman primates?
    Wesley José Santos, Lívia Maísa Guiraldi, Simone Baldini Lucheis
    American Journal of Primatology 2020 82 8
  • The looming pandemic of COVID-19
    Nasir Ali Afsar
    Journal of the Chinese Medical Association 2020 83 5
  • Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives
    Takaaki Koma, Shun Adachi, Naoya Doi, Akio Adachi, Masako Nomaguchi
    Frontiers in Microbiology 2020 11
  • COVID-19: A Devastating Pandemic
    Punet Kumar, Md Iftekhar Ahmad, Sangam Singh
    Pharmaceutical Sciences 2020 26 Covid-19
  • A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model
    David W. Hawman, Gustaf Ahlén, K. Sofia Appelberg, Kimberly Meade-White, Patrick W. Hanley, Dana Scott, Vanessa Monteil, Stephanie Devignot, Atsushi Okumura, Friedemann Weber, Heinz Feldmann, Matti Sällberg, Ali Mirazimi
    Nature Microbiology 2020
  • A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules
    Devendra Kumar, Gaurav Chauhan, Sourav Kalra, Bhupinder Kumar, Manjinder Singh Gill
    Bioorganic Chemistry 2020 104
  • A quick look at the latest developments in the COVID-19 pandemic
    Ling Xue, Jiao Li, Lin Wei, Cuiqing Ma
    Journal of International Medical Research 2020 48 9
  • Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of Critical Care
    I. B Zabolotskikh, M. Yu Kirov, K. M Lebedinskii, D. N Protsenko, S. N Avdeev, A. A Andreenko, L. V Arsentyev, V. S Afonchikov, I. I Afukov, A. A Belkin, E. A Boeva, A. Yu Bulanov, Ya. I Vasiliev, A. V Vlasenko, V. I Gorbachev, E. V Grigor’ev, S. V Grigor’ev, A. I Gritsan, A. A Eremenko, E. N Ershov, M. N Zamyatin, A. N Kuzovlev, A. V Kulikov, R. E Lakhin, I. N Leiderman, A. I Lenkin, V. A Mazurok, T. S Musaeva, E. M Nikolaenko, Yu. P Orlov, S. S Petrikov, E. V Roitman, A. M Ronenson, A. A Smetkin, A. A Sokolov, S. M Stepanenko, V. V Subbotin, N. D Ushakova, V. E Khoronenko, S. V Tsarenko, E. M Shifman, D. L Shukevich, A. V Shchegolev, A. I Yaroshetskiy, M. B Yarustovsky
    Alexander Saltanov Intensive Care Herald 2020 1S
  • Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned
    Sherif Sultan, Yogesh Acharya
    Vascular 2020
  • Antiviral treatment for COVID-19: the evidence supporting remdesivir
    Charlotte Richardson, Sanjay Bhagani, Gabriele Pollara
    Clinical Medicine 2020 20 6
  • Approaches for prevention and environmental management of novel COVID-19
    Mohammad Tabish, Aisha Khatoon, Saad Alkahtani, Abdullah Alkahtane, Jawahir Alghamdi, Syed Anees Ahmed, Snober S Mir, Gadah Albasher, Rafa Almeer, Nouf K. Al-Sultan, Nada H. Aljarba, Wedad Saeed Al-Qahtani, Mohammed AL-Zharani, Amit Kumar Nayak, Md Saquib Hasnain
    Environmental Science and Pollution Research 2020
  • Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
    Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, Grazia Graziani
    Biochemical Pharmacology 2020 180
  • COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy
    Yogesh Kumar Verma, Ranjan Verma, Nishant Tyagi, Amanpreet Behl, Subodh Kumar, Gurudutta U. Gangenahalli
    Stem Cell Reviews and Reports 2020
  • COVID-19 vaccines: The status and perspectives in delivery points of view
    Jee Young Chung, Melissa N. Thone, Young Jik Kwon
    Advanced Drug Delivery Reviews 2021 170
  • COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks
    Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner
    International Journal of Molecular Sciences 2020 21 14
  • Challenges of drug development during the COVID‐19 pandemic: Key considerations for clinical trial designs
    Jun Shi, Yubo Xiao, Yiting Zhang, Donghao Geng, Danhua Cong, Kevin X. Shi, Richard J. Knapp
    British Journal of Clinical Pharmacology 2020
  • Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and Diagnosis
    Simran Kaur, Yasha Hasija
    2021 923
  • Current Pharmacological Therapy against COVID-19: A Latin American Perspective
    Bryan Nicolalde, Diego Añazco, Mariam Mushtaq, Ana Aguilar, Enrique Terán
    Latin american journal of clinical sciences and medical technology 2020 2 2
  • Current therapies under investigation for COVID-19: potential COVID-19 treatments
    Ellen Weisberg, Martin Sattler, Priscilla L. Yang, Alexander Parent, Nathanael Gray, James D. Griffin
    Canadian Journal of Physiology and Pharmacology 2020 98 8
  • Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19
    Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, Selvaraj Kunjiappan, Joazaizulfazli Jamalis, Rafael Balaña-Fouce, Babu L. Tekwani, Murugesan Sankaranarayanan
    Bioorganic Chemistry 2020 104
  • Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics
    Mansab Ali Saleemi, Bilal Ahmad, Khaled Benchoula, Muhammad Sufyan Vohra, Hing Jian Mea, Pei Pei Chong, Navindra Kumari Palanisamy, Eng Hwa Wong
    Infection, Genetics and Evolution 2020 85
  • Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
    Manisha Yadav, Swasti Dhagat, J. Satya Eswari
    European Journal of Pharmaceutical Sciences 2020 155
  • Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics
    Ritika Kabra, Shailza Singh
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2021 1867 1
  • Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
    Inmaculada Sanclemente-Alaman, Lidia Moreno-Jiménez, María Soledad Benito-Martín, Alejandro Canales-Aguirre, Jordi A. Matías-Guiu, Jorge Matías-Guiu, Ulises Gómez-Pinedo
    Frontiers in Immunology 2020 11
  • Liver transplant immunosuppression during the COVID-19 pandemic
    Xavier Forns, Miquel Navasa
    Gastroenterología y Hepatología (English Edition) 2020 43 8
  • Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan
    Kyoji Ito, Norio Ohmagari, Ayako Mikami, Wataru Sugiura
    Global Health & Medicine 2020 2 2
  • Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
    Satarudra Prakash Singh, Manisha Pritam, Brijesh Pandey, Thakur Prasad Yadav
    Journal of Medical Virology 2021 93 1
  • Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena
    Arghadip Samaddar, Malika Grover, Vijaya Lakshmi Nag
    Frontiers in Pharmacology 2020 11
  • Remdesivir and COVID-19
    Matthew J Glaus, Serena Von Ruden
    The Lancet 2020 396 10256
  • Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19
    Pravindra Kumar, Ashok Kumar Sah, Greesham Tripathi, Anjali Kashyap, Avantika Tripathi, Rashmi Rao, Prabhu C. Mishra, Koustav Mallick, Amjad Husain, Manoj Kumar Kashyap
    Molecular and Cellular Biochemistry 2020
  • SARS-CoV-2: recommendations for treatment in intensive care medicine
    Markus Köstenberger, Walter Hasibeder, Daniel Dankl, Reinhard Germann, Christoph Hörmann, Michael Joannidis, Klaus Markstaller, Steve-Oliver Müller-Muttonen, Stefan Neuwersch-Sommeregger, Eva Schaden, Thomas Staudinger, Roman Ullrich, Andreas Valentin, Rudolf Likar
    Wiener klinische Wochenschrift 2020 132 21-22
  • Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19
    A. Acharya, R. Agarwal, M. B. Baker, J. Baudry, D. Bhowmik, S. Boehm, K. G. Byler, S. Y. Chen, L. Coates, C. J. Cooper, O. Demerdash, I. Daidone, J. D. Eblen, S. Ellingson, S. Forli, J. Glaser, J. C. Gumbart, J. Gunnels, O. Hernandez, S. Irle, D. W. Kneller, A. Kovalevsky, J. Larkin, T. J. Lawrence, S. LeGrand, S.-H. Liu, J.C. Mitchell, G. Park, J.M. Parks, A. Pavlova, L. Petridis, D. Poole, L. Pouchard, A. Ramanathan, D. M. Rogers, D. Santos-Martins, A. Scheinberg, A. Sedova, Y. Shen, J. C. Smith, M. D. Smith, C. Soto, A. Tsaris, M. Thavappiragasam, A. F. Tillack, J. V. Vermaas, V. Q. Vuong, J. Yin, S. Yoo, M. Zahran, L. Zanetti-Polzi
    Journal of Chemical Information and Modeling 2020 60 12
  • TRPV4: An Underappreciated Target to Control Alveolar Lung Edema in Severe SARS-CoV-2 Infections
    Wolfgang Kuebler, Sven-Eric Jordt, Wolfgang Liedtke
    SSRN Electronic Journal 2020
  • Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge
    Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi, Mattia Mori
    Molecules 2020 25 23
  • The novel zoonotic Coronavirus disease 2019 (COVID-19) pandemic: Health perspective on the outbreak
    M. Mazinani, B.J. Rude
    Journal of Healthcare Quality Research 2021 36 1
  • Understanding COVID-19: From Origin to Potential Therapeutics
    Muhammad Moazzam, Muhammad Imran Sajid, Hamza Shahid, Jahanzaib Butt, Irfan Bashir, Muhammad Jamshaid, Amir Nasrolahi Shirazi, Rakesh Kumar Tiwari
    International Journal of Environmental Research and Public Health 2020 17 16
  • Update on Coronavirus Disease 2019 (COVID-19)
    Teresa A Santantonio, Giovanni Messina
    The Open Neurology Journal 2020 14 1
  • Von Viren und Tieren
    Michael Groß
    Nachrichten aus der Chemie 2020 68 5
  • Potential of algal metabolites for the development of broad‐spectrum antiviral therapeutics: Possible implications in COVID ‐19 therapy
    Rimjhim Sangtani, Atreyee Ghosh, Hem C. Jha, Hamendra Singh Parmar, Kiran Bala
    Phytotherapy Research 2020
  • Review of the present features and the infection control challenges of COVID ‐19 pandemic in dialysis facilities
    Jia‐Jung Lee, Shang‐Jyh Hwang, Jee‐Fu Huang
    The Kaohsiung Journal of Medical Sciences 2020 36 6
  • A Bibliometric Network Analysis of Coronavirus during the First Eight Months of COVID-19 in 2020
    Leonardo B. Furstenau, Bruna Rabaioli, Michele Kremer Sott, Danielli Cossul, Mariluza Sott Bender, Eduardo Moreno Júdice De Mattos Farina, Fabiano Novaes Barcellos Filho, Priscilla Paola Severo, Michael S. Dohan, Nicola Luigi Bragazzi
    International Journal of Environmental Research and Public Health 2021 18 3
  • A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era
    Jinhee Lee, Han Wul Shin, Jun Young Lee, Jae Seok Kim, Jae Won Yang, Keum Hwa Lee, Andreas Kronbichler, Jae Il Shin
    Medicina 2020 56 6
  • A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children
    Andi L Shane, Alice I Sato, Carol Kao, Felice C Adler-Shohet, Surabhi B Vora, Jeffery J Auletta, Sharon Nachman, Vanessa N Raabe, Kengo Inagaki, Ibukunoluwa C Akinboyo, Charles Woods, Abdulsalam O Alsulami, Mundeep K Kainth, Roberto Parulan Santos, Claudia M Espinosa, Julianne E Burns, Coleen K Cunningham, Samuel R Dominguez, Beatriz Larru Martinez, Frank Zhu, Jonathan Crews, Taito Kitano, Lisa Saiman, Karen Kotloff
    Journal of the Pediatric Infectious Diseases Society 2020 9 5
  • A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam
    Evelyne Kestelyn, Nguyen Thi Phuong Dung, Yen Lam Minh, Le Manh Hung, Nguyen Minh Quan, Nguyen Thanh Dung, Ngo Ngoc Quang Minh, Tran Chanh Xuan, Nguyen Thanh Phong, Van Ninh Thi Thanh, Joseph Donovan, Tran Nguyen Hoang Tu, Le Thanh Hoang Nhat, Nguyen Thanh Truong, Dinh Nguyen Huy Man, Huynh Phuong Thao, Nghiêm My Ngoc, Vo Thanh Lam, Huynh Hong Phat, Phan Minh Phuong, Ronald B. Geskus, Vo Thi Nhi Ha, Nguyen Ngo Quang, Hien Tran Tinh, Le Van Tan, Guy E. Thwaites, Jeremy N. Day, Nguyen Van Vinh Chau
    Wellcome Open Research 2020 5
  • A review of Pharmacological Agents Used to Treat COVID-19 During the Pandemic.
    Fikriye Yasemin ÖZATİK
    Ahi Evran Medical Journal 2021
  • A review of medications used to control and improve the signs and symptoms of COVID-19 patients
    Kiavash Hushmandi, Saied Bokaie, Mehrdad Hashemi, Ebrahim Rahmani Moghadam, Mehdi Raei, Farid Hashemi, Mahdi Bagheri, Solomon Habtemariam, Seyed Mohammad Nabavi
    European Journal of Pharmacology 2020 887
  • Allergen fragrance molecules: a potential relief for COVID-19
    Aslı Deniz Aydın, Faruk Altınel, Hüseyin Erdoğmuş, Çağdaş Devrim Son
    BMC Complementary Medicine and Therapies 2021 21 1
  • An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses
    Golbarg Rahimi, Bahareh Rahimi, Mohammad Panahi, Shadi Abkhiz, Neda Saraygord-Afshari, Morteza Milani, Effat Alizadeh
    International Immunopharmacology 2021 92
  • An overview on the use of antivirals for the treatment of patients with COVID19 disease
    Maricar Malinis, Dayna McManus, Matthew Davis, Jeffrey Topal
    Expert Opinion on Investigational Drugs 2021 30 1
  • An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies
    Hin Fung Tsang, Lawrence Wing Chi Chan, William Chi Shing Cho, Allen Chi Shing Yu, Aldrin Kay Yuen Yim, Amanda Kit Ching Chan, Lawrence Po Wah Ng, Yin Kwan Evelyn Wong, Xiao Meng Pei, Marco Jing Woei Li, Sze-Chuen Cesar Wong
    Expert Review of Anti-infective Therapy 2020
  • Analysis and annotation of DNA methylation in two nonhuman primate species using the Infinium Human Methylation 450K and EPIC BeadChips
    Fabien Pichon, Yimin Shen, Florence Busato, Simon P Jochems, Beatrice Jacquelin, Roger Le Grand, Jean-Francois Deleuze, Michaela Müller-Trutwin, Jörg Tost
    Epigenomics 2021
  • Antiviral treatment of COVID-19: a clinical pharmacology narrative review
    Instiaty, I Gusti Agung Ayu Putu Sri Darmayani, Jefman Efendi Marzuki, Ferina Angelia, William, Angelina Siane, Lela Dwi Sary, Lina Yohanes, Reni Widyastuti, Riki Nova, Dewi Sharon Simorangkir, Lonah, Yolanda Safitri, Gestina Aliska, Anggi Gayatri
    Medical Journal of Indonesia 2020 29 3
  • Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
    Keneth Iceland Kasozi, Gniewko Niedbała, Mohammed Alqarni, Gerald Zirintunda, Fred Ssempijja, Simon Peter Musinguzi, Ibe Michael Usman, Kevin Matama, Helal F. Hetta, Ngala Elvis Mbiydzenyuy, Gaber El-Saber Batiha, Amany Magdy Beshbishy, Susan Christina Welburn
    Frontiers in Public Health 2020 8
  • COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding
    Marcelo Borges Cavalcante, Candice Torres de Melo Bezerra Cavalcante, Ana Catherine Sampaio Braga, Dennyse Araújo Andrade, Mariana Albuquerque Montenegro, Paula Andrade Neiva Santos, Paula Vitória Pereira Motoyama, Marcelo Gondim Rocha, Luciana Azôr Dib, Edward Araujo Júnior
    Geburtshilfe und Frauenheilkunde 2021 81 01
  • COVID-19: The Need for Immunoprevention at Industrial Scale
    Scott B. Halstead
    The American Journal of Tropical Medicine and Hygiene 2020 102 6
  • COVID-19: recomendaciones generales y especificaciones para el paciente con cáncer de pulmón avanzado. Revisión de la literatura
    Carla Paola Sánchez-Ríos, Miguel Ángel Ramírez-Candelas, Sergio Alejandro Menchaca-Dávila, Luis Manuel Martínez-Barrera, Jerónimo Rafael Rodríguez-Cid, Jorge Arturo Alatorre-Alexander
    NCT Neumología y Cirugía de Tórax 2020 79 2
  • Causal Therapy of COVID-19: Critical Review and Prospects
    N. V. Beloborodova, E. V. Zuev, M. N. Zamyatin, V. G. Gusarov
    General Reanimatology 2021 16 6
  • Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series
    Tao Yao, Yan Gao, Qin Cui, Bo Peng, Yan Chen, Jiansheng Li, Chao Huang, Chunping He, Jie Pu, Jiajun Wei, Yanqiang Zhan, Jie Yan, Jinghua Tian, Zhaohui Zhang, Zhichao Liu
    BMC Infectious Diseases 2020 20 1
  • Comparison of spatio-temporal transmission characteristics of COVID-19 and its mitigation strategies in China and the US
    Zhiming Feng, Chiwei Xiao, Peng Li, Zhen You, Xu Yin, Fangyu Zheng
    Journal of Geographical Sciences 2020 30 12
  • Comprehensive Literature Review and Evidence evaluation of Experimental Treatment in COVID 19 Contagion
    Umesha Boregowda, Darshan Gandhi, Nitin Jain, Kanika Khanna, Nishant Gupta
    Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2020 14
  • Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
    Shaik Mahammad Nayeem, Ershad Mohammed Sohail, Gajjela Priyanka Sudhir, Munnangi Srinivasa Reddy
    European Journal of Pharmacology 2021 890
  • Computational screening for potential drug candidates against the SARS-CoV-2 main protease
    Bruno Silva Andrade, Preetam Ghosh, Debmalya Barh, Sandeep Tiwari, Raner José Santana Silva, Wagner Rodrigues de Assis Soares, Tarcisio Silva Melo, Andria Santos Freitas, Patrícia González-Grande, Lucas Sousa Palmeira, Luiz Carlos Junior Alcantara, Marta Giovanetti, Aristóteles Góes-Neto, Vasco Ariston de Carvalho Azevedo
    F1000Research 2020 9
  • Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
    Omid Kooshkaki, Afshin Derakhshani, Andelé Marie Conradie, Nima Hemmat, Savio George Barreto, Amir Baghbanzadeh, Pankaj Kumar Singh, Hossein Safarpour, Zahra Asadzadeh, Souzan Najafi, Oronzo Brunetti, Vito Racanelli, Nicola Silvestris, Behzad Baradaran
    Frontiers in Oncology 2020 10
  • Coronavirus disease 2019 infection in patients with recent cardiac surgery: does chronic anticoagulant therapy have a protective effect?
    Giuseppe Inama, Claudio Dodi, Martino Provini, Enzo Bossoni, Lorenza Inama, Laura Balzarini, Chiara Mancini, Sara Ramponi, Maurizio Marvisi
    Journal of Cardiovascular Medicine 2020 21 10
  • Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?
    E. Chabrière
    New Microbes and New Infections 2021 39
  • Does Peer Reviewing for COVID-19-Related Papers Still Work?
    Octavio Orellana-Serradell, Magda C. Díaz, María Fernanda González, Myriam Gutiérrez, Daniela Herrera, Daniela Jara, Diego Maureira, Jenny L. Ruiz-Fuentes, Sofía Sanhueza, Lisette Leyton
    Frontiers in Research Metrics and Analytics 2020 5
  • Drug Repurposing Approaches to Combating Viral Infections
    Jay Trivedi, Mahesh Mohan, Siddappa N. Byrareddy
    Journal of Clinical Medicine 2020 9 11
  • Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study
    Yajie Meng, Min Jin, Xianfang Tang, Junlin Xu
    Applied Soft Computing 2021
  • Drug repurposing approach to combating coronavirus: Potential drugs and drug targets
    Jimin Xu, Yu Xue, Richard Zhou, Pei‐Yong Shi, Hongmin Li, Jia Zhou
    Medicinal Research Reviews 2020
  • EFFICACY AND SAFETY OF REMDESIVIR IN THE TREATMENT OF COVID 19: A RETROSPECTIVE STUDY
    Hetal Pandya, Keyur Patel, Pradeep Reddy, Pramod Jha
    GLOBAL JOURNAL FOR RESEARCH ANALYSIS 2020
  • Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials
    Desye Gebrie, Desalegn Getnet, Tsegahun Manyazewal
    BMJ Open 2020 10 6
  • Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review
    Karanvir Kaushal, Phulan Sarma, S. V. Rana, Bikash Medhi, Manisha Naithani
    Journal of Biomolecular Structure and Dynamics 2020
  • Emerging therapeutics in the management of COVID-19
    Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El-Amir, Farah Wani, Shakeel Jamal, Jagmeet Singh, Akif Kichloo
    World Journal of Virology 2021 10 1
  • Evaluation of Country Dietary Habits Using Machine Learning Techniques in Relation to Deaths from COVID-19
    María Teresa García-Ordás, Natalia Arias, Carmen Benavides, Oscar García-Olalla, José Alberto Benítez-Andrades
    Healthcare 2020 8 4
  • Exploring RdRp–remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV
    P.K. Singh, S. Pathania, R.K. Rawal
    SAR and QSAR in Environmental Research 2020 31 11
  • Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
    Stacey L. P. Scroggs, Danielle K. Offerdahl, Dylan P. Flather, Ciera N. Morris, Benjamin L. Kendall, Rebecca M. Broeckel, Paul A. Beare, Marshall E. Bloom
    Viruses 2020 13 1
  • GS-5734: a potentially approved drug by FDA against SARS-Cov-2
    Zhonglei Wang, Liyan Yang
    New Journal of Chemistry 2020 44 29
  • Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
    Rajnish Kumar, Anju Sharma, Janmejai Kumar Srivastava, Mohammed Haris Siddiqui, Md. Sahab Uddin, Lotfi Aleya
    Environmental Science and Pollution Research 2021
  • Immune response and possible therapeutics in COVID-19
    Anindya Dutta, Ananya Roy, Laboni Roy, Samit Chattopadhyay, Subhrangsu Chatterjee
    RSC Advances 2021 11 2
  • Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports
    R. S. Soumya, T. Govindan Unni, K. G. Raghu
    Cardiovascular Drugs and Therapy 2020
  • Impact of repurposed drugs on the symptomatic COVID-19 patients
    Iqbal Hussain, Afzal Hussain, Mohamed F. Alajmi, Md. Tabish Rehman, Samira Amir
    Journal of Infection and Public Health 2021 14 1
  • Inmunosupresión en el trasplante hepático en la era covid-19
    Xavier Forns, Miquel Navasa
    Gastroenterología y Hepatología 2020 43 8
  • Insights into the Origin, Transmission and Outbreak of Coronavirus Disease (Covid 19): A Recent Study
    Jhilam Majumder, Subhadeep Das, Shubhasis Dan
    Asian Journal of Chemistry 2020 32 10
  • La pandemia del nuovo coronavirus 2019 ed il trapianto renale
    Aris Tsalouchos, Maurizio Salvadori
    Giornale di Clinica Nefrologica e Dialisi 2020 32 1
  • Lesión renal aguda en COVID-19: puesta al día y revisión de la literatura
    Juan Guillermo Vargas, Natalia Avila, Diana Hurtado, Jorge Cárdenas-Roldán, Diana Peña, Guillermo Ortiz
    Acta Colombiana de Cuidado Intensivo 2020
  • Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review
    Nitalia Naidoo, Jagidesa Moodley, Thajasvarie Naicker
    Hypertension Research 2021
  • Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19
    Nidhi Singh, Sachchida Nand Rai, Veer Singh, Mohan P. Singh
    Journal of Chemical Neuroanatomy 2020 110
  • New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
    Muneerah M. Aleissa, Emily A. Silverman, Luisa M. Paredes Acosta, Cameron T. Nutt, Aaron Richterman, Francisco M. Marty
    Antimicrobial Agents and Chemotherapy 2020 65 1
  • Non-human Primate Determinants of Natural Killer Cells in Tissues at Steady-State and During Simian Immunodeficiency Virus Infection
    Nicolas Huot, Philippe Rascle, Caroline Petitdemange, Vanessa Contreras, Jean-Louis Palgen, Christiane Stahl-Hennig, Roger Le Grand, Anne-Sophie Beignon, Beatrice Jacquelin, Michaela Müller-Trutwin
    Frontiers in Immunology 2020 11
  • Ontological modeling and analysis of experimentally or clinically verified drugs against coronavirus infection
    Yingtong Liu, Junguk Hur, Wallace K. B. Chan, Zhigang Wang, Jiangan Xie, Duxin Sun, Samuel Handelman, Jonathan Sexton, Hong Yu, Yongqun He
    Scientific Data 2021 8 1
  • Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review
    Kaushik Subramanian, Anuradha Nalli, Vinitha Senthil, Saurabh Jain, Aravind Nayak, Amit Bhat
    Advances in Therapy 2020 37 10
  • Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)
    E. Díaz, R. Amézaga Menéndez, P. Vidal Cortés, M.G. Escapa, B. Suberviola, A. Serrano Lázaro, P. Marcos Neira, M. Quintana Díaz, M. Catalán González
    Medicina Intensiva (English Edition) 2021
  • Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
    Rami A. Al-Horani, Srabani Kar
    Viruses 2020 12 10
  • Potential Drugs for Treating COVID-19 Infection
    Mehrdad Mohammadi, Tim Sandle, Sajad Rajabi, Ahmad Khorshidi, Ahmad Piroozmand
    International Journal of Infection 2020 7 4
  • Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts
    Karun Neupane, Zahoor Ahmed, Hira Pervez, Rabia Ashraf, Aneela Majeed
    Cureus 2020
  • Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology
    Giuseppe Patti, Veronica Lio, Ilaria Cavallari, Felice Gragnano, Letizia Riva, Paolo Calabrò, Giuseppe Di Pasquale, Vittorio Pengo, Andrea Rubboli
    American Journal of Cardiovascular Drugs 2020 20 6
  • Race to arsenal COVID-19 therapeutics: Current alarming status and future directions
    Ankit Kumar Dubey, Aakansha Singh, Shardendu Prakash, Manoj Kumar, Ashok K Singh
    Chemico-Biological Interactions 2020 332
  • Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
    Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner
    Frontiers in Pharmacology 2020 11
  • Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2
    Muhammad Bilal, Hafiz M. N. Iqbal
    Human Vaccines & Immunotherapeutics 2020 16 12
  • Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
    Markos Kalligeros, Karen T Tashima, Evangelia K Mylona, Natasha Rybak, Timothy P Flanigan, Dimitrios Farmakiotis, Curt G Beckwith, Martha Sanchez, Marguerite Neill, Jennie E Johnson, Joseph M Garland, Su Aung, Katrina M Byrd, Thomas O’Brien, Aakriti Pandita, Jad Aridi, Raul Macias Gil, Jerome Larkin, Fadi Shehadeh, Eleftherios Mylonakis
    Open Forum Infectious Diseases 2020 7 10
  • Remdesivir and COVID-19 – Authors' reply
    Yeming Wang, Xiaoying Gu, Jiuyang Xu, Bin Cao, Chen Wang
    The Lancet 2020 396 10256
  • Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
    Richard D. Shih, Dennis G. Maki, Charles H. Hennekens
    Contemporary Clinical Trials Communications 2020 20
  • Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
    Hui Xian Jaime Lin, Sanda Cho, Veeraraghavan Meyyur Aravamudan, Hnin Yu Sanda, Raj Palraj, James S. Molton, Indumathi Venkatachalam
    Infection 2021
  • Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
    Chih-Jen Yang, Yu-Jui Wei, Hsu-Liang Chang, Pi-Yu Chang, Chung-Chen Tsai, Yen-Hsu Chen, Po-Ren Hsueh
    Journal of Microbiology, Immunology and Infection 2020
  • Remdesivir: From Ebola to COVID-19
    M. Gabriella Santoro, Ernesto Carafoli
    Biochemical and Biophysical Research Communications 2020
  • Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19
    Dingzhong Li, Jianbing Hu, Dian Li, Weijun Yang, Shuang-Feng Yin, Renhua Qiu
    Topics in Current Chemistry 2021 379 1
  • Role of Nanomedicine in Management and Prevention of COVID-19
    Jitendra N. Wankar, Vivek K. Chaturvedi, Chandrashekhar Bohara, Mohan P. Singh, Raghvendra A. Bohara
    Frontiers in Nanotechnology 2020 2
  • SARS-CoV-2 Infections and COVID-19 Fatality: Estimation of Infection Fatality Ratio and Current Prevalence
    Marco Pota, Andrea Pota, Maria Luisa Sirico, Massimo Esposito
    International Journal of Environmental Research and Public Health 2020 17 24
  • SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19
    Ilaria Vicenti, Maurizio Zazzi, Francesco Saladini
    Expert Opinion on Therapeutic Patents 2021
  • SARS-CoV-2: a new dimension to our understanding of coronaviruses
    Yusha Araf, Nairita Ahsan Faruqui, Saeed Anwar, Mohammad Jakir Hosen
    International Microbiology 2020
  • Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19
    Sugin Lal Jabaris S, Ranju V
    Pulmonary Pharmacology & Therapeutics 2021 66
  • Severe Acute Respiratory Syndrome Coronavirus 2: Genomic Observations and Emerging Therapies
    Walter Dehority, Dominique Spence, Darrell L. Dinwiddie
    Pediatric Allergy, Immunology, and Pulmonology 2020 33 2
  • Status of Remdesivir: Not Yet Beyond Question!
    Saptarshi Chatterjee
    Archives of Medical Research 2021 52 1
  • Technological evolution of cyclodextrins in the pharmaceutical field
    Juliana Rincón-López, Yara C. Almanza-Arjona, Alejandro P. Riascos, Yareli Rojas-Aguirre
    Journal of Drug Delivery Science and Technology 2020
  • The Impacts of Antivirals on the Coronavirus Genome Structure and Subsequent Pathogenicity, Virus Fitness and Antiviral Design
    Ching-Hung Lin, Cheng-Yao Yang, Shan-Chia Ou, Meilin Wang, Chen-Yu Lo, Tsung-Lin Tsai, Hung-Yi Wu
    Biomedicines 2020 8 10
  • The SARS-CoV-2, a new pandemic zoonosis that threatens the world
    J. Reina
    Vacunas (English Edition) 2020 21 1
  • The interplay between emerging human coronavirus infections and autophagy
    Zhenyu Zhao, Kefeng Lu, Binli Mao, Shi Liu, Mirko Trilling, Ailong Huang, Mengji Lu, Yong Lin
    Emerging Microbes & Infections 2021
  • The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2
    Zhenming Jin, Haofeng Wang, Yinkai Duan, Haitao Yang
    Biochemical and Biophysical Research Communications 2020
  • The past, present and future of RNA respiratory viruses: influenza and coronaviruses
    Vadim Makarov, Olga Riabova, Sean Ekins, Nikolay Pluzhnikov, Sergei Chepur
    Pathogens and Disease 2020 78 7
  • The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo
    Christin Müller, Wiebke Obermann, Nadja Karl, Hans-Guido Wendel, Gaspar Taroncher-Oldenburg, Stephan Pleschka, Roland K. Hartmann, Arnold Grünweller, John Ziebuhr
    Antiviral Research 2021 186
  • Therapeutic options for COVID-19: a quick review
    Muhammad Sani Ismaila, Faruku Bande, Aminu Ishaka, Aminatu Abubakar Sani, Karla Georges
    Journal of Chemotherapy 2021
  • Therapeutic targets and potential agents for the treatment of COVID‐19
    Yinuo Wu, Zhe Li, Yun‐Song Zhao, Yi‐You Huang, Mei‐Yan Jiang, Hai‐Bin Luo
    Medicinal Research Reviews 2021
  • Tratamiento farmacológico de la COVID-19: revisión narrativa de los Grupos de Trabajo de Enfermedades Infecciosas y Sepsis (GTEIS) y del Grupo de Trabajo de Transfusiones Hemoderivados (GTTH)
    E. Díaz, R. Amézaga Menéndez, P. Vidal Cortés, M.G. Escapa, B. Suberviola, A. Serrano Lázaro, P. Marcos Neira, M. Quintana Díaz, M. Catalán González
    Medicina Intensiva 2020
  • Treating COVID-19: are we missing out the window of opportunity?
    Jeremiah Sundararaj Stanleyraj, Nandini Sethuraman, Rajesh Gupta, Sohanlal Thiruvoth, Manisha Gupta, Akihide Ryo
    Journal of Antimicrobial Chemotherapy 2021 76 2
  • Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function
    Hilary Miller-Handley, Keith Luckett, Amit Govil
    Advances in Chronic Kidney Disease 2020 27 5
  • Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review
    Reem Hanna, Snehal Dalvi, Tudor Sălăgean, Ioana Delia Pop, Ioana Roxana Bordea, Stefano Benedicenti
    Journal of Inflammation Research 2021 Volume 14
  • Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
    Yinan Xiao, Hanyue Xu, Wen Guo, Yunuo Zhao, Yuling Luo, Ming Wang, Zhiyao He, Zhenyu Ding, Jiyan Liu, Lei Deng, Fushen Sha, Xuelei Ma
    Molecular Biomedicine 2020 1 1
  • Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies
    K. Ghazvini, M. Keikha
    Le Pharmacien Hospitalier et Clinicien 2020
  • What are the drugs having potential against COVID-19?
    Kaan Kucukoglu, Nagihan Faydalı, Dilek Bul
    Medicinal Chemistry Research 2020 29 11
  • Will Remdesivir Reshape Cardiovascular Practice in COVID 19 Era?
    A. Mohammed Idhrees, Prasanna Karthik Suthakaran, George Jose Valooran, Mohamad Bashir
    International Journal of Angiology 2020
  • mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
    A. A. Ilyichev, L. A. Orlova, S. V. Sharabrin, L. I. Karpenko
    Vavilov Journal of Genetics and Breeding 2020 24 7
  • Çocuklarda COVID-19 Tedavisi
    Belgin GÜLHAN, Aslınur ÖZKAYA PARLAKAY
    Turkish Journal of Pediatric Disease 2020

Article usage

Article usage: February 2020 to January 2021

AbstractFullPdf
Feb 20201669304553653
Mar 20202433208886300
Apr 20201801120795777
May 2020118958322758
Jun 20203842663819
Jul 20202552575643
Aug 20201701550400
Sep 20202281297404
Oct 20203911817490
Nov 20202451196293
Dec 2020183822180
Total 202089488117421717
Jan 2021119843178
Total 2021119843178
Total90678201721895
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit, Friederike Feldmann, Jacqueline Cronin, Robert Jordan, Atsushi Okumura, Tina Thomas, Dana Scott, Tomas Cihlar, Heinz Feldmann
Proceedings of the National Academy of Sciences Mar 2020, 117 (12) 6771-6776; DOI: 10.1073/pnas.1922083117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit, Friederike Feldmann, Jacqueline Cronin, Robert Jordan, Atsushi Okumura, Tina Thomas, Dana Scott, Tomas Cihlar, Heinz Feldmann
Proceedings of the National Academy of Sciences Mar 2020, 117 (12) 6771-6776; DOI: 10.1073/pnas.1922083117
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 117 (12)
Table of Contents

Submit

Sign up for Article Alerts

Article Classifications

  • Biological Sciences
  • Microbiology

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Abstract depiction of a guitar and musical note
Science & Culture: At the nexus of music and medicine, some see disease treatments
Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
Image credit: Shutterstock/agsandrew.
Large piece of gold
News Feature: Tracing gold's cosmic origins
Astronomers thought they’d finally figured out where gold and other heavy elements in the universe came from. In light of recent results, they’re not so sure.
Image credit: Science Source/Tom McHugh.
Dancers in red dresses
Journal Club: Friends appear to share patterns of brain activity
Researchers are still trying to understand what causes this strong correlation between neural and social networks.
Image credit: Shutterstock/Yeongsik Im.
Yellow emoticons
Learning the language of facial expressions
Aleix Martinez explains why facial expressions often are not accurate indicators of emotion.
Listen
Past PodcastsSubscribe
Goats standing in a pin
Transplantation of sperm-producing stem cells
CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
Image credit: Jon M. Oatley.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490